ARCHIVES

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

Crico-Pharyngeal Myotomoy To Be Assessed in Trial

October 4, 1985

Freireich Blasts Prevention Advocates, Defends Treatment

September 15, 1978

Healthcare Utilization Figures More Than Biology In Disparity

April 30, 2010

In Brief; NCAB To Hear Report On Human Cancer Virus, Mayo Projects, Proposed FDA Regulations

February 28, 1975

NCI To Seek Cancer Act Changes On Center Grant Limits

April 9, 1976

Mass. Public Health Commissioner Koh Named To NCAB; Kovach To Direct Long Island Center.

October 27, 2000